identified a novel epitope polypeptide from EML4-ALK fused NSCLC, and at the same time successfully induced a restricted polypeptide specific CTL clone with significant cytotoxic effects on EML4-ALK positive NSCLC cells. Here, EML4 is linked to non-small cell lung carcinoma.